# Voyager Therapeutics (VYGR) — News

VYGR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vygr/news

## Recent headlines

- [Nurix Therapeutics Q3 net income USD 549.807 million](https://www.ainvest.com/news/nurix-therapeutics-q3-net-income-usd-549-807-million-2610) — AInvest Wire, Oct 12, 2026
  Nurix Therapeutics reported a net income of USD 549.807 million for the third quarter of 2026, reflecting strong financial performance during the period. The company’s results highlight its continued progress in the biotechnology sector, particularly in the development of genetic medicines for…
- [Protagonist Therapeutics, Inc.: Leerink partners assumes coverage with outperform rating; target price $190](https://www.ainvest.com/news/protagonist-therapeutics-leerink-partners-assumes-coverage-outperform-rating-target-price-190-2610) — AInvest Wire, Oct 12, 2026
  Leerink Partners has initiated coverage of Protagonist Therapeutics, Inc. with an "outperform" rating and a target price of $190 per share. The decision reflects the firm’s assessment of the company’s therapeutic pipeline and its potential for long-term growth. While specific details of the firm’s…
- **Important** — Voyager Therapeutics up 8% following quarterly beats — AInvest Wire, May 13, 2024
  Voyager Therapeutics up 8% following quarterly beats Voyager Therapeutics (VYGR) experienced a notable 8% increase in its stock price following the release of its third-quarter financial results [1]. The biotech company reported encouraging developments in its pipeline, particularly in its efforts…
- **Important** — Voyager Therapeutics shares leap 31% premarket on Novartis collaboration — AInvest Wire, Jan 2, 2024
  Voyager Therapeutics shares leap 31% premarket on Novartis collaboration Voyager Therapeutics, a clinical-stage gene therapy company, has recently announced a collaboration with Novartis, a global pharmaceutical company, which has caused a surge in Voyager's stock price. According to a report by…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).